A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease
BACKGROUND:<br>Chronic obstructive pulmonary disease (COPD) is a common lung disorder characterized by persistent and progressive airflow limitation as well as systemic changes. Metabolic changes in blood may help detect COPD in an earlier stage and predict prognosis. <br><br>METHO...
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
BioMed Central
2020
|
| _version_ | 1826301101415071744 |
|---|---|
| author | Prokić, I Lahousse, L de Vries, M Liu, J Kalaoja, M Vonk, JM van der Plaat, DA van Diemen, CC van der Spek, A Zhernakova, A Fu, J Ghanbari, M Ala-Korpela, M Kettunen, J Havulinna, AS Perola, M Salomaa, V Lind, L Ärnlöv, J Stricker, BHC Brusselle, GG Boezen, HM van Duijn, CM Amin, N |
| author_facet | Prokić, I Lahousse, L de Vries, M Liu, J Kalaoja, M Vonk, JM van der Plaat, DA van Diemen, CC van der Spek, A Zhernakova, A Fu, J Ghanbari, M Ala-Korpela, M Kettunen, J Havulinna, AS Perola, M Salomaa, V Lind, L Ärnlöv, J Stricker, BHC Brusselle, GG Boezen, HM van Duijn, CM Amin, N |
| author_sort | Prokić, I |
| collection | OXFORD |
| description | BACKGROUND:<br>Chronic obstructive pulmonary disease (COPD) is a common lung disorder characterized by persistent and progressive airflow limitation as well as systemic changes. Metabolic changes in blood may help detect COPD in an earlier stage and predict prognosis. <br><br>METHODS:<br>We conducted a comprehensive study of circulating metabolites, measured by proton Nuclear Magnetic Resonance Spectroscopy, in relation with COPD and lung function. The discovery sample consisted of 5557 individuals from two large population-based studies in the Netherlands, the Rotterdam Study and the Erasmus Rucphen Family study. Significant findings were replicated in 12,205 individuals from the Lifelines-DEEP study, FINRISK and the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) studies. For replicated metabolites further investigation of causality was performed, utilizing genetics in the Mendelian randomization approach. <br><br>RESULTS:<br>There were 602 cases of COPD and 4955 controls used in the discovery meta-analysis. Our logistic regression results showed that higher levels of plasma Glycoprotein acetyls (GlycA) are significantly associated with COPD (OR = 1.16, P = 5.6 × 10- 4 in the discovery and OR = 1.30, P = 1.8 × 10- 6 in the replication sample). A bi-directional two-sample Mendelian randomization analysis suggested that circulating blood GlycA is not causally related to COPD, but that COPD causally increases GlycA levels. Using the prospective data of the same sample of Rotterdam Study in Cox-regression, we show that the circulating GlycA level is a predictive biomarker of COPD incidence (HR = 1.99, 95%CI 1.52-2.60, comparing those in the highest and lowest quartile of GlycA) but is not significantly associated with mortality in COPD patients (HR = 1.07, 95%CI 0.94-1.20). <br><br>CONCLUSIONS:<br>Our study shows that circulating blood GlycA is a biomarker of early COPD pathology. |
| first_indexed | 2024-03-07T05:27:16Z |
| format | Journal article |
| id | oxford-uuid:e0ff470e-8d94-4d9d-8c6c-9c5e6ba3f5a1 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:27:16Z |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:e0ff470e-8d94-4d9d-8c6c-9c5e6ba3f5a12022-03-27T09:51:26ZA cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary diseaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e0ff470e-8d94-4d9d-8c6c-9c5e6ba3f5a1EnglishSymplectic ElementsBioMed Central2020Prokić, ILahousse, Lde Vries, MLiu, JKalaoja, MVonk, JMvan der Plaat, DAvan Diemen, CCvan der Spek, AZhernakova, AFu, JGhanbari, MAla-Korpela, MKettunen, JHavulinna, ASPerola, MSalomaa, VLind, LÄrnlöv, JStricker, BHCBrusselle, GGBoezen, HMvan Duijn, CMAmin, NBACKGROUND:<br>Chronic obstructive pulmonary disease (COPD) is a common lung disorder characterized by persistent and progressive airflow limitation as well as systemic changes. Metabolic changes in blood may help detect COPD in an earlier stage and predict prognosis. <br><br>METHODS:<br>We conducted a comprehensive study of circulating metabolites, measured by proton Nuclear Magnetic Resonance Spectroscopy, in relation with COPD and lung function. The discovery sample consisted of 5557 individuals from two large population-based studies in the Netherlands, the Rotterdam Study and the Erasmus Rucphen Family study. Significant findings were replicated in 12,205 individuals from the Lifelines-DEEP study, FINRISK and the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) studies. For replicated metabolites further investigation of causality was performed, utilizing genetics in the Mendelian randomization approach. <br><br>RESULTS:<br>There were 602 cases of COPD and 4955 controls used in the discovery meta-analysis. Our logistic regression results showed that higher levels of plasma Glycoprotein acetyls (GlycA) are significantly associated with COPD (OR = 1.16, P = 5.6 × 10- 4 in the discovery and OR = 1.30, P = 1.8 × 10- 6 in the replication sample). A bi-directional two-sample Mendelian randomization analysis suggested that circulating blood GlycA is not causally related to COPD, but that COPD causally increases GlycA levels. Using the prospective data of the same sample of Rotterdam Study in Cox-regression, we show that the circulating GlycA level is a predictive biomarker of COPD incidence (HR = 1.99, 95%CI 1.52-2.60, comparing those in the highest and lowest quartile of GlycA) but is not significantly associated with mortality in COPD patients (HR = 1.07, 95%CI 0.94-1.20). <br><br>CONCLUSIONS:<br>Our study shows that circulating blood GlycA is a biomarker of early COPD pathology. |
| spellingShingle | Prokić, I Lahousse, L de Vries, M Liu, J Kalaoja, M Vonk, JM van der Plaat, DA van Diemen, CC van der Spek, A Zhernakova, A Fu, J Ghanbari, M Ala-Korpela, M Kettunen, J Havulinna, AS Perola, M Salomaa, V Lind, L Ärnlöv, J Stricker, BHC Brusselle, GG Boezen, HM van Duijn, CM Amin, N A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease |
| title | A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease |
| title_full | A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease |
| title_fullStr | A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease |
| title_full_unstemmed | A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease |
| title_short | A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease |
| title_sort | cross omics integrative study of metabolic signatures of chronic obstructive pulmonary disease |
| work_keys_str_mv | AT prokici acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT lahoussel acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT devriesm acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT liuj acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT kalaojam acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT vonkjm acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT vanderplaatda acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT vandiemencc acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT vanderspeka acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT zhernakovaa acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT fuj acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT ghanbarim acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT alakorpelam acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT kettunenj acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT havulinnaas acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT perolam acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT salomaav acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT lindl acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT arnlovj acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT strickerbhc acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT brussellegg acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT boezenhm acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT vanduijncm acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT aminn acrossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT prokici crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT lahoussel crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT devriesm crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT liuj crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT kalaojam crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT vonkjm crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT vanderplaatda crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT vandiemencc crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT vanderspeka crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT zhernakovaa crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT fuj crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT ghanbarim crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT alakorpelam crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT kettunenj crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT havulinnaas crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT perolam crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT salomaav crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT lindl crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT arnlovj crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT strickerbhc crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT brussellegg crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT boezenhm crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT vanduijncm crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease AT aminn crossomicsintegrativestudyofmetabolicsignaturesofchronicobstructivepulmonarydisease |